This study evaluated the NSCLC-SAQ's measurement properties within a clinical trial. Methods:The KEYNOTE-598 phase 3 study of participants with stage IV metastatic NSCLC with programmed death-ligand 1 tumor proportion score greater than or equal to 50% was used to assess the NSCLC-SAQ's ...
Development of a Patient-Reported Outcome Instrument to Evaluate Symptoms of Advanced NSCLC: Qualitative Research and Content Validity of the Non-Small Cel... .Qualitativedevelopment and content validity of the non-small cell lung cancersymptom assessment questionnaire (NSCLC-SAQ), a patient-reported ...
To date, meaningful within-patient change (MWPC) thresholds have only been proposed for NSCLC-SAQ total score. This study proposed clinically MWPC thresholds, and group-level minimal important change/difference (MIC/MID) thresholds for both improvement and worsening for the Non-Small Cell Lung ...
Qualitative development and content validity of the non-small cell lung cancer symptom assessment questionnaire(NSCLC-SAQ), A patient reported outcome instrument [ J ]. Clinical Therapeu- tics,2016,38 (4) :794- 810.McCarrier KP, Atkinson TM, Debusk KPA, Liepa AM, Scanlon M, Coons SJ. ...
PROMIS PF-SF analyses included data from 300 participants in the PAPILLON trial, and NSCLC-SAQ analyses included 615 participants in the MARIPOSA 2 trial . Prespecified expected relationships between target PRO measures and relevant study variables were used to evaluate validity evidence. Additionally, ...